A detailed picture of what happens when DNA transcription is paused early in the process has been obtained by structural ...

Known as promoter-proximal pausing, this interruption in the transcription activity of RNA polymerase II—the enzyme ...

Pfizer (PFE) stock and BioNTech (BNTX) stock in focus as FDA may not renew the authorization for their pediatric COVID shot. Read more here.

Trump administration has unwisely cancelled mRNA vaccine research while doing little about Americans’ unhealthy diet.

The company is not developing an mRNA vaccine, but had been using one as the control in a 10,000-subject Phase IIb trial.

Researchers at Fred Hutch Cancer Center invented a new screening method called ReLiC that uses CRISPR-Cas9 to test all the ...

Market to Reach $430 Million by 2032, Driven by Breakthrough Clinical Trials and Expanding Indications. The global RNA-Based Therape ...

NIH director Jay Bhattacharya has offered a new explanation for why the federal government canceled $500 million in contracts ...

The potential move to rescind authorization of Pfizer's vaccine could leave some kids in the U.S. with no available shots ...

NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with ...

The government’s cancellation of almost $500 million in contracts involving mRNA vaccines could halt progress on cancer ...

Return on Equity (ROE): Arcturus Therapeutics's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of -5.93%, the company showcases ...